e 4031 has been researched along with Neoplasms in 2 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moccia, M | 1 |
| Frett, B | 1 |
| Zhang, L | 1 |
| Lakkaniga, NR | 1 |
| Briggs, DC | 1 |
| Chauhan, R | 1 |
| Brescia, A | 1 |
| Federico, G | 1 |
| Yan, W | 1 |
| Santoro, M | 1 |
| McDonald, NQ | 1 |
| Li, HY | 1 |
| Carlomagno, F | 1 |
| He, S | 1 |
| Moutaoufik, MT | 1 |
| Islam, S | 1 |
| Persad, A | 1 |
| Wu, A | 1 |
| Aly, KA | 1 |
| Fonge, H | 1 |
| Babu, M | 1 |
| Cayabyab, FS | 1 |
1 review available for e 4031 and Neoplasms
| Article | Year |
|---|---|
HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinogenesis; Cell Movement; Cell Proliferation; | 2020 |
1 other study available for e 4031 and Neoplasms
| Article | Year |
|---|---|
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Discovery; Female; Humans; Mice; Mice, Inbred | 2020 |